VCEL
Vericel Corporation
NASDAQ · Healthcare · Biotechnology · US
$40.19
−0.69%Leverage
- Debt / equity
- 0.25x
- Net debt / equity
- -0.09x
- Debt / assets
- 0.18x
- Debt / EBITDA
- 2.41x
- Net debt / EBITDA
- -0.85x
Liquidity & coverage
- Current ratio
- 5.04x
- Quick ratio
- 4.69x
- Cash ratio
- 3.09x
- Interest coverage
- 28.49x
- EBITDA / interest
- 60.08x
- Working capital
- $212.2M
Cash & dividend
- FCF / debt
- 0.54x
- Cash flow / debt
- 0.75x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026